共查询到17条相似文献,搜索用时 171 毫秒
1.
2.
3.
4.
5.
选取90例缓慢性心律失常患者,按照随机分配原则,将患者分为治疗组和对照组,每组45例。分别应用24h动态心电图(Holter)及心电图的诊断方法后,进行为期1个月的治疗,前者选用复心脉方,后者选用常规治疗,观察治疗前后变化。缓慢性心律失常患者心电图及Holter等心电监测明显异常。经临床治疗1个月,治疗组和对照组均可改善患者心悸、胸闷、面色苍白、头晕耳鸣、气短乏力、口唇发绀等症状,除气短乏力外,治疗组疗效均明显优于对照组,差异具有统计学意义(P0.05)。两组在治疗前后均可有效提高患者的总心率、平均心率、最大心率、最慢心率,且治疗组效果明显优于对照组,差异具有统计学意义(P0.05)。心电图及24h心电图是缓慢性心律失常的确诊方式,但心电图优于24h心电图,可更广好地作为缓慢性心律失常的诊断标准。复心脉方在改善缓慢性心律失常患者的各种临床症状方面有显著疗效,且能提高患者总心率、平均心率、最大心率、最慢心率,并能降低患者血清血脂,对改善缓慢性心律失常具有显著的临床疗效。 相似文献
6.
目的应用综合指数与粗糙集理论联用法评价人群血常规指标,为评价相关指标健康风险状况提供参考依据。方法回顾性分析2016-2020年广东地区送往广州达安临床检验中心的20023份血常规标本检验数据,建立指数分析(综合指数)与风险分析(粗糙集理论)联用法评价人群血常规8项指标健康水平,即红细胞计数(RBC)、平均红细胞容积(MCV)、血红蛋白(Hb)、平均红细胞血红蛋白量(MCH)、平均红细胞血红蛋白浓度(MCHC)、血细胞比容(HCT)、白细胞计数(WBC)和血小板计数(PLT)。结果广东整体人群血液健康指数(BHI)均值为0.774,其中老年人群为0.742、男性人群为0.758、非老年人群为0.794、女性人群为0.790。2016-2019年各类人群BHI值均表现为逐渐降低,2020年略有上升。在单项指标中,MCHC的健康指数(1.280~1.398)和MCV的健康指数(0.834~1.010)均明显高于其他指标。风险分析提示MCHC在各类人群中均存在较高风险,风险覆盖度分别为整体人群9.362‰、男性人群13.242‰、女性人群20.831‰、老年人群5.579‰和非老年人群7.547‰。结论综合指数与粗糙集理论联用法可以评价人群血常规指标健康风险状况,2016-2020年广东地区人群血常规健康程度为合格水平且表现为总体上升,MCHC和MCV指标对广东地区人血常规健康影响较大,同时在各类人群中MCHC指标均提示不同概率的风险,应加强监测。 相似文献
7.
腰身指数与心血管代谢危险的关系研究 总被引:1,自引:0,他引:1
目的 研究分析腰身指数与心血管代谢危险的关系.方法 按标准方法测量腰围、身高和进行各种生化检测,并将腰围/身高的指数按≥0.5和<0.5分为两组,分别比较两组间收缩压、舒张压、胆固醇、三酰甘油酯、高密度脂蛋白、低密度脂蛋白、尿酸等心血管代谢危险指标的差异以及与高血压、高血脂、高血糖、高屎酸、高体重等心血管危险各症患症率之间的差异.结果 腰身指教按≥0.5组与<0.5组比较,收缩压、舒张压、胆固醇、三酰甘油酯、高密度脂蛋白、低密度脂蛋白、尿酸均有非常显著性差异(均P<0.01);高血压、高血糖、高血脂、高尿酸、高体重的患症率亦均有非常显著性差异(均P<0.01).结论 腰身指数与心血管代谢危险各指标和各患症率均有明显的关系.腰身指数可作为预测和评估心血管代谢危险的一个重要指标. 相似文献
8.
9.
目的 探讨健康管理对改善体检人群体重指数(BMI)的效果。方法 随机抽取2009年在我院体检中心进行健康体检的四个单位职工进行健康管理。针对个体不良生活方式因素,制定个体化的健康生活方式指导方案,给予个体化、针对性的指导。针对肥胖人群、超重人群、正常人群分别以一个月、一个月、三个月的周期电话进行跟踪干预管理。对干预前、干预后BMI增高检出情况进行比较。结果 健康管理一年后,体检结果显示健康管理试点单位人群中BMI增高者减少118人,下降5.80%,与干预前比较P<0.01,有显著性差异。男职工BMI增高者减少92例,下降6.50%;女职工BMI增高者减少26例,下降4.25%。男女职工比较P<0.05,有显著性差异,男职工健康管理的效果更明显。结论 健康管理可有效改善体检人群不良生活方式,降低体重指数,从而降低生活方式疾病风险,是干预人群一级预防的有效方法。 相似文献
10.
11.
12.
13.
Glucagon: present status in cardiovascular disease 总被引:2,自引:0,他引:2
14.
15.
Introduction: Hyperhomocysteinemia has been considered as a risk factor for systemic atherosclerosis, cardiovascular disease (CVD) and stroke and many epidemiologic and case-controlled studies have demonstrated its association with these complications. In addition, treatment of hyperhomocysteinemia with folic acid ± B vitamins prevents the development of atherosclerosis, CVD and strokes. However, subsequent prospective, randomized, placebo-controlled trials have not shown an association of high homocysteine levels or their lowering with treatment with the incidence of atherosclerosis, CVD or strokes, due possibly, to the fortification of flower with folic acid. Therefore, at present, there is a controversy regarding the significance of homocysteine as a risk factor for CVD and stroke and whether patients should be routinely screened for homocysteine.
Areas covered: For these reasons, a focused Medline search of the English language literature was conducted between 2010 and 2017 using the terms, homocysteine, risk factor, atherosclerosis, cardiovascular disease, stroke, treatment, and 38 papers with pertinent information were selected.
Expert commentary: The review of data disclosed that there is a great controversy regarding the significance of homocysteine as a risk factor for CVD and stroke. The data from these papers together with collateral literature will be discussed in this mini review. 相似文献
16.
This review article provides an overview of the use of contrast-enhanced ultrasound (CEUS) in China. Currently, the only licensed
contrast agent is SonoVue, a sulfur hexafluoride-filled microbubble contrast agent. In combination with a low mechanical index
contrast-specific imaging mode, SonoVue-enhanced CEUS can be used to visualize the micro and macro-vasculature continuously.
Since 2004, CEUS has been widely used in China in various clinical scenarios. The authors compared CEUS with baseline ultrasound
or contrast-enhanced computed tomography with regard to characterization of focal liver lesions (FLLs). On CEUS, heterogeneous
or homogeneous hyperenhancement during the arterial phase and washout in the portal/late phase are typical findings for hepatocellular
carcinoma. The enhancement features of intrahepatic cholangiocarcinoma, infected FLLs, focal fatty infiltration, focal fatty
sparing, complex cystic FLLs, and uncommon benign FLLs were carefully depicted. CEUS was also used for patient selection in
ablation therapy and evaluation of response to ablation for liver cancer. The utility of three-dimensional CEUS of the liver
was also explored. In non-liver use, CEUS in hilar cholangiocarcinoma, gallbladder, breast, and prostate was initially investigated.
In addition, CEUS was used in interventional procedures such as CEUS-guided hemostatic injection, intraoperative CEUS in neurosurgery,
and evaluation of response to high-intensity focused ultrasound ablation of uterine fibroids. The Chinese experience has resulted
in increased use of CEUS. 相似文献
17.
PURPOSE: To review the literature for, and provide advanced practice nurses (APNs) with, current recommendations for screening and treatment of hyperhomocysteinemia. DATA SOURCES: Medscape literature search of selected research studies and related journal articles. CONCLUSIONS: While data from most epidemiologic studies support the argument that hyperhomocysteinemia is an independent risk factor for cardiovascular disease, the debate continues as to when screening and treating patients is appropriate. The consensus is that more randomized controlled trials are needed to further study the benefits of routine screening and the efficacy of treating hyperhomocysteinemia. IMPLICATIONS FOR PRACTICE: Until the results of ongoing clinical trials are available, APNs should follow the American Heart Association guidelines for screening for elevated levels of homocysteine and continue to promote a well-balanced diet that includes foods rich in folic acid as part of health promotion through primary prevention. 相似文献